Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
128,514
Value
$38.7M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026128,514$38.7M0.1%−45,499−26.1%ReducedHolders
Q1 2026174,013$57.6M0.1%−37,064−17.6%ReducedHolders
Q4 2025211,077$83.9M0.1%+206,446+4,457.9%AddedHolders
Q3 20254,631$2.11M<0.1%+390+9.2%AddedHolders
Q2 20254,241$1.38M<0.1%−1,599−27.4%ReducedHolders
Q1 20255,840$1.58M<0.1%−270−4.4%ReducedHolders
Q4 20246,110$1.44M<0.1%−1,476−19.5%ReducedHolders
Q3 20247,586$2.09M<0.1%−223−2.9%ReducedHolders
Q2 20247,809$1.90M<0.1%−1,018−11.5%ReducedHolders
Q1 20248,827$1.32M<0.1%+809+10.1%AddedHolders
Q4 20238,018$1.53M<0.1%−154−1.9%ReducedHolders
Q3 20238,172$1.45M<0.1%+115+1.4%AddedHolders
Q2 20238,057$1.53M<0.1%−757−8.6%ReducedHolders
Q1 20238,814$1.77M<0.1%−3,227−26.8%ReducedHolders
Q4 202212,041$2.86M<0.1%+33+0.3%AddedHolders
Q3 202212,008$2.40M<0.1%+619+5.4%AddedHolders
Q2 202211,389$1.66M<0.1%−3,801−25.0%ReducedHolders
Q1 202215,190$2.48M<0.1%−4,656−23.5%ReducedHolders
Q4 202119,846$3.37M<0.1%−8,361−29.6%ReducedHolders
Q3 202128,207$5.33M<0.1%+2,838+11.2%AddedHolders
Q2 202125,369$4.30M<0.1%+6,983+38.0%AddedHolders
Q1 202118,386$2.60M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.